Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Hemcheck Sweden

Less than 1K followers
All
Press releases
ShowingAll content types
Regulatory press release5/28/2025, 1:30 PM

Kallelse till Årsstämma i Bio Vitos Pharma AB (publ)

Hemcheck Sweden
Regulatory press release3/25/2025, 3:35 PM

Bio Vitos Pharma AB: Nasdaq drar tillbaka disciplinärende

Hemcheck Sweden
Regulatory press release3/25/2025, 7:35 AM

Bio Vitos Pharma AB: Bio Vitos Pharma ändrar datum för publicering av årsredovisning och årsstämma

Hemcheck Sweden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release3/19/2025, 10:20 AM

Bio Vitos Pharma AB: Uppdatering kring studien avseende järnsuccinat

Hemcheck Sweden
Regulatory press release3/15/2025, 2:35 PM

Bio Vitos Pharma AB: Nasdaq har beslutat att avnotera bolagets aktier

Hemcheck Sweden
Regulatory press release2/28/2025, 7:30 AM

Bio Vitos Pharma AB: Bio Vitos Pharma:s bokslutskommuniké för 2024

Hemcheck Sweden
Regulatory press release2/11/2025, 8:45 AM

Bio Vitos Pharma AB: Bio Vitos ändrar datum för publicering av bokslutskommunikén

Hemcheck Sweden
Regulatory press release2/7/2025, 6:34 PM

Bio Vitos Pharma AB: Avtal med certified advisor uppsagt

Hemcheck Sweden
Regulatory press release1/10/2025, 3:20 PM

Bio Vitos Pharma AB: Bio Vitos ingår förlikningsavtal

Hemcheck Sweden
Regulatory press release12/19/2024, 10:30 AM

Bio Vitos Pharma AB: Ytterligare information om Sven Rohmann ny tf VD

Hemcheck Sweden
Regulatory press release12/18/2024, 6:00 PM

Bio Vitos Pharma AB: Sven Rohmann utses till ny tf VD

Hemcheck Sweden
Regulatory press release12/18/2024, 5:20 PM

Bio Vitos Pharma AB: Bio Vitos ersätter befintlig kreditfacilitet med ny

Hemcheck Sweden
Regulatory press release12/12/2024, 7:05 PM

Bio Vitos Pharma AB: Bio Vitos Pharma har erhållit anmärkningspåstående från Nasdaq med yrkande om avnotering

Hemcheck Sweden
Regulatory press release11/18/2024, 10:55 AM

Bio Vitos Pharma AB: Första deltagarna kallas till kliniska tester

Hemcheck Sweden
Regulatory press release11/15/2024, 7:30 AM

Bio Vitos Pharma AB: Bio Vitos Pharma:s kvartalsrapport för tredje kvartalet 2024

Hemcheck Sweden
Regulatory press release11/13/2024, 2:15 PM

Bio Vitos Pharma AB (publ) utser LAGO KAPITAL till likviditetsgarant

Hemcheck Sweden
Regulatory press release11/13/2024, 2:15 PM

Bio Vitos Pharma AB (publ) appoints LAGO KAPITAL as liquidity provider

Hemcheck Sweden
Regulatory press release11/13/2024, 9:55 AM

Bio Vitos Pharma AB: Bio Vitos Pharma ingår långsiktigt IR-partnerskap med Börsjakten Holding AB

Hemcheck Sweden
Regulatory press release11/12/2024, 10:30 AM

Bio Vitos Pharma AB: Information till aktieägare i Hemcheck Holding AB

Hemcheck Sweden
Regulatory press release11/11/2024, 12:40 PM

Bio Vitos Pharma AB: Bio Vitos Pharma ingår avtal om att avyttra verksamhet

Hemcheck Sweden
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.